Serial Number | 97583720 |
Word Mark | ANFYBI |
Filing Date | Thursday, September 8, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, July 9, 2024 |
Registration Number | 7436262 |
Registration Date | Tuesday, July 9, 2024 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 23, 2024 |
Goods and Services | Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 14, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Ipsen Pharma S.A.S. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 34 - NOT AVAILABLE |
Address | Boulogne-Billancourt 92100 FR |
Party Name | Ipsen Pharma S.A.S. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 34 - NOT AVAILABLE |
Address | Boulogne-Billancourt 92100 FR |
Party Name | Ipsen Pharma S.A.S. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 34 - NOT AVAILABLE |
Address | Boulogne-Billancourt 92100 FR |
Event Date | Event Description |
Monday, September 12, 2022 | NEW APPLICATION ENTERED |
Wednesday, September 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, June 22, 2023 | ASSIGNED TO EXAMINER |
Monday, June 26, 2023 | NON-FINAL ACTION WRITTEN |
Monday, June 26, 2023 | NON-FINAL ACTION E-MAILED |
Monday, June 26, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, September 19, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, February 9, 2024 | ASSIGNED TO LIE |
Friday, February 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, February 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, February 28, 2024 | ASSIGNED TO EXAMINER |
Friday, March 1, 2024 | SUSPENSION LETTER WRITTEN |
Friday, March 1, 2024 | LETTER OF SUSPENSION E-MAILED |
Friday, March 1, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, March 12, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Wednesday, March 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, March 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, March 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 3, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 23, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, April 23, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, July 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |